ThermoGenesis (KOOL -3.5%) slides in spite of its earlier announcement of an order for its AXP...
ThermoGenesis (KOOL -3.5%) slides in spite of its earlier announcement of an order for its AXP AutoXpress System from Crioestaminal, a leading cord blood stem cell bank located in Portugal. Terms of the deal were not disclosed. The AXP System is an automated device with companion sterile blood processing disposables for harvesting cord blood stem cells in closed systems. Crioestaminal is considered a major European cord blood bank.
From other sites
at Benzinga.com (Jan 2, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs